Phase 3 Ankylosing Spondylitis Trial, Recruiting NCT06860750 Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. Condition: Ankylosing Spondylitis
Back to Ankylosing Spondylitis

Phase 3 Ankylosing Spondylitis Trial, Recruiting

NCT06860750
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older at the time of signing the consent form, regardless of gender
  • Your Body Mass Index (BMI — a measure based on your height and weight) is 18 or above at the time of screening
  • You have measurable signs of inflammation in your body at the time of screening
  • You are willing to voluntarily sign a consent form before any study activities begin
  • You are able to communicate clearly with the research team and are willing to follow all study requirements throughout the trial

Who may not be able to join:

  • You currently have an active widespread infection or a serious infection
  • You currently have active tuberculosis (TB) or have a hidden/inactive TB infection
  • You have lymphoma or a disease involving abnormal growth of lymph cells
  • You have high blood pressure that is not well controlled by treatment
  • You have been diagnosed with any form of cancer in the past 5 years, or currently have cancer
  • You have moderate to severe heart failure
  • You have previously had an organ transplant, or have a serious, worsening, or uncontrolled condition affecting any major organ system
  • You have certain abnormal results in blood tests or heart tracing (ECG) tests at the time of screening (confirm with trial site)
  • You are currently pregnant or breastfeeding
  • You have a known allergy to the study drug or any of its ingredients
  • You have had a problem with alcohol misuse or illegal drug use in the past year
  • You have received a live vaccine (such as certain flu or travel vaccines) in the 12 weeks before joining, or plan to receive one during the study
  • You have donated around 500 mL of blood in the 8 weeks before joining, or plan to donate blood during the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +86-0518-82342973

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Registry
ClinicalTrials.gov
Start date
29 April 2025
Est. completion
1 February 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Proportion of participants achieving ASAS 40 (ankylosing spondylitis disease activity score).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov